Generated by AI
HeartBeam, Inc. is a medical technology company that develops cardiac diagnostic solutions for use both inside and outside clinical settings. The company’s core offering is a portable, cable-free ECG platform designed to capture the heart’s electrical activity from three dimensions and synthesize it into a 12-lead ECG for physician review. Its products and software are aimed at helping clinicians detect and monitor arrhythmias and other cardiac conditions through remote and ambulatory workflows. HeartBeam’s current product portfolio includes a patient-held ECG device, a companion mobile application, physician software, and cloud-based analysis tools that support cardiac assessment and care coordination. Based in Santa Clara, California, HeartBeam operates in the healthcare technology market, with a focus on ambulatory cardiovascular diagnostics and telehealth-enabled cardiac monitoring.
Website2118 Walsh Avenue
Santa Clara, CA, 95050
United States
The latest articles about BEAT.
Detailed price information for Ferrari N.V. (RACE-N) from The Globe and Mail including charting and trades.
HeartBeam Inc (BEAT) advances its 510(k) heart attack detection pathway with strong ALIGN ACS results and extended runway into 2027, while Nasdaq compliance and pivotal study timing remain key risks.
Summary of Nov 17's posts. Generated by AI.
Summary of Nov 13's posts. Generated by AI.
Summary of Oct 29's posts. Generated by AI.
Summary of Nov 17's posts. Generated by AI.
Investors talking about BEAT also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.